Epsilon Healthcare Ltd has released a press release.
THC Global Shareholder Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Epsilon Healthcare Limited on 6ix
Earlier from Epsilon Healthcare
- Manufacturing Permit Received for Southport Facility
- THC Global Builds New Zealand CBD Presence
- Two Facilities Receive S4 and S8 Narcotics Licences
- THC Global Corporate Presentation - Sept 2019
- THC Global secures 24.6ha cannabis cultivation site
Later from Epsilon Healthcare
- First Medicinal Cannabis Processed at Southport Facility
- Product Supply Agreement Signed with MGC Pharma
- TGA GMP Manufacturing Licence Granted for Southport Facility
- Launch of Australian and International Medicines Supply
- Production commenced to support 6000 Australian Patients
Follow Epsilon Healthcare into a list and get an email when it puts out news.
Follow Epsilon Healthcare